VB Spine completed the acquisition of Stryker’s spine implant manufacturing facility in Cestas, France. Known for its state-of-the-art operations and technical capabilities, the Cestas facility will play a central role in VB Spine’s global manufacturing strategy.
Related: W.L. Gore to acquire left atrial appendage device maker Conformal Medical
This milestone expands on the April 1, 2025 formation of VB Spine, established through the acquisition of Stryker’s U.S. spine implant business. VB Spine operates independently under the leadership of Marc, John, and Anthony Viscogliosi, co-founders of Viscogliosi Brothers, LLC.
The acquisition brings with it the site’s people, infrastructure, and processes. It also creates opportunities to expand VB Spine’s medical education and training programs in Europe.
“The team in Cestas brings deep expertise and a strong track record in manufacturing excellence,” said John Viscogliosi, co-CEO of VB Spine. “We’re thrilled to welcome them to VB Spine and excited for the role they will play in our future. Cestas will anchor our worldwide manufacturing capabilities and give us a strong platform to deliver training and best practices to surgeons.”
Transition Highlights:
- Employees transitioned from Stryker to VB Spine
- Manufacturing operations continue without interruption
- Integration planning is well underway to align systems, quality, and supply chain
With the Cestas facility now part of VB Spine, the company expands its global presence and strengthens its commitment to advance spine care globally.
Forward-Looking Statements
Certain statements in this release are forward-looking and are based on current expectations, forecasts, and assumptions. Actual results may differ materially due to regulatory, commercial, and operational risks. VB Spine disclaims any obligation to update forward-looking statements except as required by law.
Transaction Financing
Viscogliosi Brothers, LLC and Viscogliosi Brothers Watermark Holdings LLC are equity investors in VB Spine.
